Endocrine MediaSite

177 Lu-labeled EB-RGD Targets Integrin α V β 3 Receptors in Thyroid Cancers with BRAF-like Genetic Signature

Please complete the form here or contact [email protected] to learn more about licensing content from the Endocrine Society.

If you believe you should have access to this media, please login.

<sup>177</sup>Lu-labeled EB-RGD Targets Integrin α<sub>V</sub>β<sub>3</sub> Receptors in Thyroid Cancers with BRAF-like Genetic Signature

Related Media